The FDA gave the greenlight to transcatheter pulmonic valve replacement with the Sapien 3 system plus an adaptive pre-stent landing zone, dubbed Alterra, for patients with congenital heart disease.
Pulmonary valve stenosis can be both congenital (present at birth) or something adults develop later on in life. It can range in severity from mild to severe cases. Often, a person may not know they ...
The US Food and Drug Administration has approved the Harmony transcatheter pulmonary valve (TPV) system (Medtronic) as the first nonsurgical heart valve to treat pulmonary-valve regurgitation in ...
For years, innovations in the treatment of pulmonary valve regurgitation have relied on invasive surgical treatments—until now. A device from Medtronic that takes a minimally invasive approach to ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. At 10 years, transcatheter pulmonary valve replacement ...
The FDA approved a new version of Edwards Lifesciences’ Sapien 3 transcatheter heart valve—coupling it with a self-expanding, stent-like device that helps reshape a malfunctioning pulmonary valve.
The US Food and Drug Administration (FDA) has cleared Edwards Lifesciences’ SAPIEN 3 transcatheter valve with the Alterra adaptive prestent for pulmonic heart valve replacement, the manufacturer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results